Three-year follow-up of a novel aqueous humor microshunt

Batlle J.F., Fantes F., Riss I., Pinchuk L., Alburquerque R., Kato Y.P., Arrieta E., Peralta A.C., Palmberg P., Parrish R.K., II, Weber B.A., Parel J.-M.

2016
Journal of Glaucoma

View publication

Therapeutic Area

Glaucoma
Categories

Clinical development

Affiliations

Centro Laser, Santo Domingo, Dominican Republic; Ophthalmic Biophysics Center Bascom Palmer Eye Institute, University of MiamiMiller School of Medicine, United States; Anne Bates Leach Eye Hospital, University of Miami, United States; InnFocus Inc., Miami, FL, United States; Pôle Ophtalmologique de la Clinique Mutualiste, Pessac, Cedex, France

Related Publications

Metabolomic Profiling of Open-Angle Glaucoma Etiologic Endotypes: Tohoku Multi-Omics Glaucoma Study

Hanyuda A.; Raita Y.; Ninomiya T.; Hashimoto K.; Takada N.; Sato K.; Inoue J.; Koshiba S.; Tamiya G.; Narita A.; Akiyama M.; Omodaka K.; Tsuda S.; Yokoyama Y.; Himori N.; Yamamoto Y.; Taniguchi T.; Negishi K.; Nakazawa T.

Ocular Tissue Distribution of Omidenepag Isopropyl in Rabbits and Cynomolgus Monkeys

Yamamura K.; Mano H.; Fuwa M.; Ryoiwamura; Odani-Kawabata N.

Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial

Wang T.H.; Aung T.; Lu D.-W.; George R.; Senthil S.; Lu F.; Odani-Kawabata N.; Park K.H.

View all Glaucoma publications